{"title":"Cis- and trans-regulation of Irf8 enhancers during dendritic cell development.","authors":"Akira Nishiyama, Tomohiko Tamura","doi":"10.1016/j.exphem.2025.104858","DOIUrl":null,"url":null,"abstract":"<p><p>Dendritic cells (DCs) are mononuclear phagocytes that play a crucial role in the immune system by mediating innate and adaptive immunity. DC differentiation requires the establishment of DC-specific gene expression regulated by lineage-specific transcription factors. Recent studies have reported a series of transcription factors essential for DC differentiation, as well as the regulatory circuit composed of these transcription factors. Among these transcription factors, interferon regulatory factor 8 (IRF8) is pivotal for the differentiation of type 1 classical DCs (cDC1s). IRF8 establishes the enhancer landscape at the progenitor stage and also regulates the higher-order chromatin structure of cDC1-specific genes. Furthermore, the cell fate within the myeloid lineages is determined in an IRF8 dose-dependent manner. The enhancers that govern Irf8 expression have been identified and extensively studied. Notably, Irf8 expression is regulated by a complex interplay among 3' enhancers, each of which has a differentiation stage-specific effect. In this review, we discuss recent advances in our understanding of the regulatory mechanisms of IRF8 expression underlying cDC1 development.</p>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":" ","pages":"104858"},"PeriodicalIF":2.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.exphem.2025.104858","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/16 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Dendritic cells (DCs) are mononuclear phagocytes that play a crucial role in the immune system by mediating innate and adaptive immunity. DC differentiation requires the establishment of DC-specific gene expression regulated by lineage-specific transcription factors. Recent studies have reported a series of transcription factors essential for DC differentiation, as well as the regulatory circuit composed of these transcription factors. Among these transcription factors, interferon regulatory factor 8 (IRF8) is pivotal for the differentiation of type 1 classical DCs (cDC1s). IRF8 establishes the enhancer landscape at the progenitor stage and also regulates the higher-order chromatin structure of cDC1-specific genes. Furthermore, the cell fate within the myeloid lineages is determined in an IRF8 dose-dependent manner. The enhancers that govern Irf8 expression have been identified and extensively studied. Notably, Irf8 expression is regulated by a complex interplay among 3' enhancers, each of which has a differentiation stage-specific effect. In this review, we discuss recent advances in our understanding of the regulatory mechanisms of IRF8 expression underlying cDC1 development.
期刊介绍:
Experimental Hematology publishes new findings, methodologies, reviews and perspectives in all areas of hematology and immune cell formation on a monthly basis that may include Special Issues on particular topics of current interest. The overall goal is to report new insights into how normal blood cells are produced, how their production is normally regulated, mechanisms that contribute to hematological diseases and new approaches to their treatment. Specific topics may include relevant developmental and aging processes, stem cell biology, analyses of intrinsic and extrinsic regulatory mechanisms, in vitro behavior of primary cells, clonal tracking, molecular and omics analyses, metabolism, epigenetics, bioengineering approaches, studies in model organisms, novel clinical observations, transplantation biology and new therapeutic avenues.